ONCY Stock Price Increases Over 60% Pre-Market: Why It Happened

By Amit Chowdhry ● February 17, 2021
  • The stock price of Oncolytics Biotech, Inc. (NASDAQ: ONCY) is trading at over 60% pre-market. This is why it happened.

The stock price of Oncolytics Biotech, Inc. (NASDAQ: ONCY) is trading at over 60% pre-market. One of the biggest catalysts appears to be H.C. Wainwright initiating coverage of Oncolytics Biotech with a “Buy” rating and a $15 price target.

In a research report via TheFly, H.C. Wainwright analyst Patrick Trucchio noted that the company is “on the cusp of demonstrating potential to upend the treatment paradigms of several cancers.”

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.